TCL-495 Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing

Keyphrases

• Whole Exome Sequencing 100%
• Whole Genome Sequencing 100%
• Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) 100%
• Tumor 15%
• Recurrent mutation 15%
• Copy number Aberrations 15%
• Mouse Model 7%
• Tumor Samples 7%
• Lymphoma Patients 7%
• Gene mutation 7%
• Large Cohort 7%
• Single Institution 7%
• Disease Genome 7%
• Cancer Center 7%
• Jewish 7%
• T-cell Lymphoma 7%
• Exome 7%
• Missense mutation 7%
• Small Sample Size 7%
• JAK-STAT Pathway 7%
• Illumina 7%
• Long Genes 7%
• Normal Breast 7%
• Chromosome 11 7%
• Fluids Samples 7%
• Textured Implants 7%
• Genomic Evaluation 7%
• STAT3 mutation 7%
• ATM Gene 7%
• Germline Predisposition 7%
• IT Platform 7%
• Illumina NovaSeq 6000 7%

Medicine and Dentistry

• Genome Sequencing 100%
• Anaplastic Large Cell Lymphoma 100%
• Exome Sequencing 100%
• Breast Implant 100%
• Whole Genome Sequencing 30%
• Neoplasm 23%
• Malignant Neoplasm 7%
• Exome 7%
• Disease Predisposition 7%
• Gene Mutation 7%
• Implant 7%
• Missense Mutation 7%
• T-Cell Lymphoma 7%
• Chromosome 11 7%
• Complex Genomic Disorder 7%
• Germ Cell 7%

Biochemistry, Genetics and Molecular Biology

• Exome Sequencing 100%
• Whole Genome Sequencing 100%
• Germline 20%
• Germ Cell 20%
• Mouse Model 20%
• T Cell 20%
• Exome 20%
• Gene Mutation 20%
• Liquid 20%
• Complex Genomic Disorder 20%
• Missense Mutation 20%
• Sample Size 20%
• STAT3 20%
• Chromosome 11 20%